CAS 86925-97-5 | N-Benzyloxycarbonylprolylprolinal | CAS Number 86925-97-5

200,000+ products from a single source!

sales@angenechem.com

Product Categories

Home > Other Building Blocks > 86925-97-5

86925-97-5 | N-Benzyloxycarbonylprolylprolinal

CAS No: 86925-97-5 Catalog No: AG004OE6 MDL No:

Product Description

Catalog Number:

AG004OE6

Chemical Name:

N-Benzyloxycarbonylprolylprolinal

CAS Number:

86925-97-5

Molecular Formula:

C18H22N2O4

Molecular Weight:

330.3783

IUPAC Name:

benzyl (2S)-2-[(2S)-2-formylpyrrolidine-1-carbonyl]pyrrolidine-1-carboxylate

InChI:

InChI=1S/C18H22N2O4/c21-12-15-8-4-10-19(15)17(22)16-9-5-11-20(16)18(23)24-13-14-6-2-1-3-7-14/h1-3,6-7,12,15-16H,4-5,8-11,13H2/t15-,16-/m0/s1

InChI Key:

ORZXYSPOAVJYRU-HOTGVXAUSA-N

SMILES:

O=C[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)OCc1ccccc1

Properties

Complexity:

476

Compound Is Canonicalized:

Yes

Covalently-Bonded Unit Count:

Defined Atom Stereocenter Count:

Defined Bond Stereocenter Count:

Exact Mass:

330.158g/mol

Formal Charge:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Isotope Atom Count:

Molecular Weight:

330.384g/mol

Monoisotopic Mass:

330.158g/mol

Rotatable Bond Count:

Topological Polar Surface Area:

66.9A^2

Undefined Atom Stereocenter Count:

Undefined Bond Stereocenter Count:

XLogP3:

1.7

Literature

Title	Journal
Prolyl endopeptidase is involved in cellular signalling in human neuroblastoma SH-SY5Y cells.	Neuro-Signals 20110101
Structural analysis of prolyl oligopeptidases using molecular docking and dynamics: insights into conformational changes and ligand binding.	PloS one 20110101
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.	Bioorganic & medicinal chemistry letters 20101101
Inhibition of prolyl oligopeptidase with a synthetic unnatural dipeptide.	Bioorganic & medicinal chemistry 20100701
Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors.	Journal of medicinal chemistry 20100513
Molecular dynamics study of prolyl oligopeptidase with inhibitor in binding cavity.	SAR and QSAR in environmental research 20091001
Intracellular activation and deactivation of tasidotin, an analog of dolastatin 15: correlation with cytotoxicity.	Molecular pharmacology 20090101
Pharmacokinetics in mice implanted with xenografted tumors after intravenous administration of tasidotin (ILX651) or its carboxylate metabolite.	The AAPS journal 20070901
A prolyl oligopeptidase inhibitor, Z-Pro-Prolinal, inhibits glyceraldehyde-3-phosphate dehydrogenase translocation and production of reactive oxygen species in CV1-P cells exposed to 6-hydroxydopamine.	Toxicology in vitro : an international journal published in association with BIBRA 20061201
Dicarboxylic acid azacycle l-prolyl-pyrrolidine amides as prolyl oligopeptidase inhibitors and three-dimensional quantitative structure-activity relationship of the enzyme-inhibitor interactions.	Journal of medicinal chemistry 20050728
Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP.	Hypertension (Dallas, Tex. : 1979) 20040501
Two peptidase activities decrease in treated bipolar disorder not schizophrenic patients.	Bipolar disorders 20040401
New bioactive diterpene polyesters from Euphorbia decipiens.	Journal of natural products 20030901
Dicarboxylic acid bis(L-prolyl-pyrrolidine) amides as prolyl oligopeptidase inhibitors.	Journal of medicinal chemistry 20020926
A prolyl endopeptidase-inhibiting benzofuran dimer from Polyozellus multiflex.	Journal of natural products 20020101
Purification and characterization of a Z-pro-prolinal-insensitive Z-Gly-Pro-7-amino-4-methyl coumarin-hydrolyzing peptidase from bovine serum--a new proline-specific peptidase.	Protein expression and purification 20010701
New prolyl endopeptidase inhibitors: in vitro and in vivo activities of azabicyclo[2.2.2]octane, azabicyclo[2.2.1]heptane, and perhydroindole derivatives.	Journal of medicinal chemistry 19960607